Joint pain relief from a supplement? small study tests new hope for breast cancer survivors.

NCT ID NCT07199556

Completed Symptom relief Sponsor: Arafarma Group, S.A. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a collagen-based food supplement (Tenflex®) in 30 women with breast cancer who had joint pain from hormone therapy (aromatase inhibitors). The goal was to see if pain levels improved over 12 weeks. The supplement is already sold as a food product, so this is an early test of its potential benefit for this specific side effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tenflex® (collagen and chondroitin sulfate food supplement)
What this could lead to: If it works, this could offer a simple, non-drug option to reduce joint pain for women on hormone therapy after breast cancer.
What could go wrong: This is a very small pilot study with only 30 participants and no placebo group, so results may not be reliable or apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Locations

Hospital Clínic Barcelona

Barcelona, 08036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.